New molecular discovery is beneficial for treating cerebral ischemia

Cuban researchers have recently discovered a new type of molecule called JM-20, and have demonstrated the ability of neuroprotective drugs in preclinical studies of this molecule , promising to Very useful in the treatment of cerebral anemia.

JM-20 and derivatives are protected by a complete Cuban patent.(Artwork: digitaltrends.com).

Daily newspaper Granma said this is the basic foundation for subsequent human clinical trials and once the ability is demonstrated, JM-20 molecule will be first introduced in the market as a product. therapy.

The Granma newspaper did not provide further scientific data on the new molecule, but asserted that JM-20 and its derivatives were protected by a complete Cuban patent.

A total of 5 units and science centers participated in the study, in which, in addition to Cuban facilities, there was the Basic Medical Science Institute of Brazil's Rio Grande do Sul State University.

In 2015, the molecular detection JM-20 received the award of the Cuban Academy of Sciences for the health sector and the special award of the Cuban Ministry of Science, Technology and Environment for the scientific work. Best turn of the year.